Works matching Isoniazid


Results: 5000
    1

    Quantification of pyrazinamide, isoniazid, acetyl‐isoniazid, and rifampicin by a high‐performance liquid chromatography method in human plasma from patients with tuberculosis.

    Published in:
    Journal of Separation Science, 2021, v. 44, n. 2, p. 521, doi. 10.1002/jssc.202000672
    By:
    • Hernández‐González, Oswaldo;
    • Zarazúa, Sergio;
    • Veytia‐Bucheli, José Ignacio;
    • González‐Chávez, Marco Martín;
    • Rodríguez‐Pinal, Cristian Jazmín;
    • Medellín‐Garibay, Susanna Edith;
    • Uresti‐Rivera, Edith Elena;
    • Pérez‐Vázquez, Francisco Javier;
    • Portales‐Pérez, Diana Patricia;
    • Romano‐Moreno, Silvia;
    • Milán‐Segovia, Rosa del Carmen
    Publication type:
    Article
    2
    3
    4

    High-Dose Isoniazid Lacks EARLY Bactericidal Activity against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized Phase II Clinical Trial.

    Published in:
    American Journal of Respiratory & Critical Care Medicine, 2024, v. 210, n. 3, p. 343, doi. 10.1164/rccm.202311-2004OC
    By:
    • Gausi, Kamunkhwala;
    • Ignatius, Elisa H.;
    • De Jager, Veronique;
    • Upton, Caryn;
    • Kim, Soyeon;
    • McKhann, Ashley;
    • Moran, Laura;
    • Wiesner, Lubbe;
    • von Groote-Bidlingmaier, Florian;
    • Marzinek, Philip;
    • Vanker, Naadira;
    • Yvetot, Joseph;
    • Pierre, Samuel;
    • Rosenkranz, Susan L.;
    • Swindells, Susan;
    • Diacon, Andreas H.;
    • Nuermberger, Eric L.;
    • Denti, Paolo;
    • Dooley, Kelly E.
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    30
    31
    32
    33

    Bacterial risk factors for treatment failure and relapse among patients with isoniazid resistant tuberculosis.

    Published in:
    2018
    By:
    • Thai, Phan Vuong Khac;
    • Ha, Dang Thi Minh;
    • Hanh, Nguyen Thi;
    • Day, Jeremy;
    • Dunstan, Sarah;
    • Nhu, Nguyen Thi Quynh;
    • Kiet, Vo Sy;
    • Lan, Nguyen Huu;
    • Dung, Nguyen Huy;
    • Lan, Nguyen Thi Ngoc;
    • Thuong, Nguyen Thuong;
    • Lan, Nguyen Ngoc;
    • Liễu, Phạm Thị Thúy;
    • Hồng, Nguyễn Thị;
    • Điệp, Đào Công;
    • Thanh, Nguyễn Thị Kim;
    • Hội, Nguyễn Văn;
    • Nghĩa, Nguyễn Văn;
    • Đại, Trương Ngọc;
    • Minh, Hoàng Quang
    Publication type:
    journal article
    34
    35

    Extracorporeal treatments for isoniazid poisoning: Systematic review and recommendations from the EXTRIP workgroup.

    Published in:
    Pharmacotherapy, 2021, v. 41, n. 5, p. 463, doi. 10.1002/phar.2519
    By:
    • Mowry, James B.;
    • Shepherd, Greene;
    • Hoffman, Robert S.;
    • Lavergne, Valery;
    • Gosselin, Sophie;
    • Nolin, Thomas D.;
    • Vijayan, Anitha;
    • Kielstein, Jan T.;
    • Roberts, Darren M.;
    • Ghannoum, Marc;
    • Alhatali, Badria;
    • Anseeuw, Kurt;
    • Bird, Steven;
    • Berling, Ingrid;
    • Bouchard, Josée;
    • Bunchman, Timothy E.;
    • Calello, Diane P.;
    • Chin, Paul K.;
    • Doi, Kent;
    • Galvao, Tais
    Publication type:
    Article
    36

    NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: A randomized controlled trial for pharmacogenetics-based therapy.

    Published in:
    European Journal of Clinical Pharmacology, 2013, v. 69, n. 5, p. 1091, doi. 10.1007/s00228-012-1429-9
    By:
    • Azuma, Junichi;
    • Ohno, Masako;
    • Kubota, Ryuji;
    • Yokota, Soichiro;
    • Nagai, Takayuki;
    • Tsuyuguchi, Kazunari;
    • Okuda, Yasuhisa;
    • Takashima, Tetsuya;
    • Kamimura, Sayaka;
    • Fujio, Yasushi;
    • Kawase, Ichiro
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50